no long term data
#retatrutide 2024-04-22
Monday20 messages4 participantstimes are UTC
Highlights from this day
- taper_tess — phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan 19:51
- vial_ledger — anyone stayed at 1.7 for months rather than climbing the heart rate thing is real enough that i mention it whenever someone asks about starting 20:20
- vial_ledger — held at 2.5 for 4 months and it never plateaued for me, which i cant explain, happy to be corrected 20:22
- VialBot — Digest for the week of 2024-01-01 has been published. 20:35
- taper_tess — research use only is on every vial and i treat it as exactly that, nobody here is prescribing 20:56
phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan
⚠️10🤝8
*PeptideMeter not the other one
TRIUMPH is phase 3
research use only
my resting heart rate is up about 4 bpm, did that settle for anyone
glucagon is the new bit
[edited]anyone stayed at 1.7 for months rather than climbing
the heart rate thing is real enough that i mention it whenever someone asks about starting
held at 2.5 for 4 months and it never plateaued for me, which i cant explain, happy to be corrected
fridge-temps.csv
873 rows · not retained in the public archive
phase 2 only
smaller steps here
is the GI worse than tirzepatide or about the same
[edited]mine went up too
the heart rate thing is real enough that i mention it whenever someone asks about starting
Digest for the week of 2024-01-01 has been published.
🎉3
low and slow
cant feel it honestly
research use only is on every vial and i treat it as exactly that, nobody here is prescribing
📉1👀2📈17
ok so is there any long term safety data at all or is it phase 2 and hope
triple agonist meaning GLP-1, GIP and glucagon, have i got that right